Can Entresto cause hypotension?
Yes. Entresto (sacubitril/valsartan) can lower blood pressure, and hypotension is a known risk. This is especially relevant early after starting the drug and after dose increases, and in people who already have low baseline blood pressure or are prone to dehydration/low volume states.
Who is most likely to develop low blood pressure on Entresto?
People with higher risk for hypotension tend to include those who:
- Start with lower baseline blood pressure
- Are taking diuretics or have recently had aggressive diuresis (higher chance of low intravascular volume)
- Have dehydration or poor oral intake
- Have kidney problems where fluid balance and drug handling can be more sensitive
- Are titrated to higher doses quickly
Clinicians often adjust diuretic strategy and titration pace to reduce this risk.
What does hypotension on Entresto feel like?
Symptoms can include dizziness, lightheadedness, fainting (syncope), weakness, or blurred vision—especially when standing up. If someone develops these symptoms after starting or increasing Entresto, it often prompts checking blood pressure and reassessing volume status and dosing.
What should patients do if they get dizzy or have low blood pressure?
Patients should contact their prescriber promptly if they experience symptoms of low blood pressure. Typical management decisions (made by the clinician) may include:
- Rechecking home blood pressure measurements and timing (for example, around doses)
- Reviewing other blood pressure-lowering medicines
- Adjusting diuretic dose or addressing dehydration
- Slowing or temporarily pausing dose titration
- Reducing the Entresto dose if symptoms are significant or persistent
Urgent care is appropriate for fainting, severe dizziness, chest pain, shortness of breath, or signs of shock.
Is hypotension a reason to stop Entresto?
It can be, depending on severity and recurrence. Mild, transient drops that do not cause symptoms may be handled with monitoring and slower titration. Symptomatic hypotension or persistent low readings despite dose and volume adjustments may require dose reduction, delaying titration, or stopping the medication.
Does Entresto hypotension differ from ACE-inhibitor hypotension?
Both classes can lower blood pressure, but Entresto’s mechanism (neprilysin inhibition plus ARB activity) means blood pressure effects can show up after initiation and titration. The practical takeaway is similar: starting dose and titration pace, plus diuretic/volume status management, strongly influence hypotension risk.
When does hypotension usually happen after starting?
Hypotension is most likely around the start of therapy and after dose changes, when the body is adjusting to the new blood pressure-lowering effect and changes in volume status.
Can Entresto be used if someone already has low blood pressure?
It may still be possible, but it requires careful clinician selection and titration. People with very low baseline blood pressure may not tolerate standard initiation, and prescribers may choose lower starting doses, slower titration, and tighter monitoring.
Are there alternatives if Entresto causes problematic hypotension?
If Entresto cannot be tolerated due to blood pressure effects, clinicians may consider switching to an alternative guideline-directed heart failure therapy that has a different blood pressure profile. The best option depends on the underlying diagnosis (heart failure with reduced vs. preserved ejection fraction), kidney function, heart rate, and current medications.
If you share your situation—your baseline blood pressure, current Entresto dose, when symptoms started (and whether you’re on diuretics)—I can explain what questions to ask your clinician and what adjustments are commonly considered.